secwatch.observer — SEC 8-K summary
======================================

Issuer:     Streamex Corp. (STEX)
CIK:        0001530766
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001493152-24-023293
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioSig Technologies appoints Ferdinand Groenewald as interim CFO after Hrkac resignation
--------------------------------------------------------------------------------

- Frederick Hrkac resigned as acting CFO and principal accounting officer effective June 5, 2024.
- Ferdinand Groenewald appointed interim CFO, principal accounting officer, VP finance under consulting agreement.
- Groenewald compensation: $15,000 per month plus expense reimbursement; currently VP Finance at Alaunos Therapeutics.
- Groenewald previously served as CFO of Muscle Maker, Inc. and director of HeartCore and SYLA Technologies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer